Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027

Bonafide Trust 30-06-2021 139 Pages Figures : 67 Tables : 80
Region : Global Category : Lifescience Pharmaceutical

Request new version

Request for updated version of the report at the same price

Order Now

Report Description
Table of Contents
List of Figure Tables

Global amyotrophic lateral sclerosis treatment market will reach $762.3 million by 2027, growing by 5.8% annually over 2020-2027 owing to the increasing geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies. Highlighted with 80 tables and 67 figures, this 139-page report “Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027 by Treatment Type (Medication, Stem Cell Therapy, Others), ALS Type (Sporadic, Familial), Distribution Channel, and Region: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire global amyotrophic lateral sclerosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global amyotrophic lateral sclerosis treatment market in every aspect of the classification from perspectives of Treatment Type, ALS Type, Distribution Channel, and Region. Based on Treatment Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Medication • Riluzole (Rilutek) • Radicava (Edaravone) • Tiglutik (Thickened Riluzole) • Nuedexta • Stem Cell Therapy • Other Treatments Based on ALS Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Sporadic ALS • Familial ALS Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • Other Distribution Channels Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • North America (U.S., Canada, and Mexico) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of all regional markets by country and split of key national markets by Treatment Type, ALS Type, and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): AB Science SA Amylyx Pharmaceuticals Inc. Biogen Inc. Biohaven Pharmaceutical Holding Co., Ltd. BrainStorm Cell Limited Corestem, Inc. F.Hoffmann-La Roche AG Ionis Pharmaceuticals, Inc. Mitsubishi Tanabe Pharma Corporation Otsuka Pharmaceutical Co., Ltd. Sun Pharmaceutical Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on World Economy 21

2.1.2 Impact of COVID-19 on the Market 23

2.2 Major Growth Drivers 25

2.3 Market Restraints and Challenges 29

2.4 Emerging Opportunities and Market Trends 32

2.5 Porter’s Fiver Forces Analysis 36

3 Segmentation of Global Market by Treatment Type 40

3.1 Market Overview by Treatment Type 40

3.2 Medication 42

3.3 Stem Cell Therapy 44

3.4 Other Treatments 45

4 Segmentation of Global Market by ALS Type 46

4.1 Market Overview by ALS Type 46

4.2 Sporadic ALS 48

4.3 Familial ALS 49

5 Segmentation of Global Market by Distribution Channel 50

5.1 Market Overview by Distribution Channel 50

5.2 Hospital Pharmacies 52

5.3 Retail Pharmacies 53

5.4 Online Pharmacies 54

5.5 Other Distribution Channels 55

6 Segmentation of Global Market by Region 56

6.1 Geographic Market Overview 2020-2027 56

6.2 North America Market 2020-2027 by Country 60

6.2.1 Overview of North America Market 60

6.2.2 U.S. 63

6.2.3 Canada 66

6.2.4 Mexico 68

6.3 European Market 2020-2027 by Country 70

6.3.1 Overview of European Market 70

6.3.2 UK 73

6.3.3 France 75

6.3.4 Germany 77

6.3.5 Spain 79

6.3.6 Italy 81

6.3.7 Russia 83

6.3.8 Rest of European Market 85

6.4 Asia-Pacific Market 2020-2027 by Country 87

6.4.1 Overview of Asia-Pacific Market 87

6.4.2 China 90

6.4.3 Japan 92

6.4.4 India 95

6.4.5 Australia 97

6.4.6 South Korea 99

6.4.7 Rest of APAC Region 101

6.5 South America Market 2020-2027 by Country 103

6.5.1 Argentina 106

6.5.2 Brazil 108

6.5.3 Chile 110

6.5.4 Rest of South America Market 112

6.6 MEA Market 2020-2027 by Country 113

6.6.1 UAE 116

6.6.2 Saudi Arabia 118

6.6.3 South Africa 120

6.6.4 Other National Markets 122

7 Competitive Landscape 123

7.1 Overview of Key Vendors 123

7.2 New Product Launch, Partnership, Investment, and M&A 126

7.3 Company Profiles 127

AB Science SA 127

Amylyx Pharmaceuticals Inc. 129

Biogen Inc. 130

Biohaven Pharmaceutical Holding Co., Ltd. 131

BrainStorm Cell Limited 132

Corestem, Inc. 133

F.Hoffmann-La Roche AG 134

Ionis Pharmaceuticals, Inc. 135

Mitsubishi Tanabe Pharma Corporation 136

Otsuka Pharmaceutical Co., Ltd. 137

Sun Pharmaceutical Industries Ltd. 138

RELATED REPORTS 139

Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 18
Figure 4. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. Primary Restraints and Impact Factors of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter’s Fiver Forces Analysis of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 36
Figure 11. Breakdown of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2020-2027, % of Revenue 40
Figure 12. Contribution to Global 2021-2027 Cumulative Revenue by Treatment Type, Value ($ mn) and Share (%) 41
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication, 2017-2027, $ mn 42
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Stem Cell Therapy, 2017-2027, $ mn 44
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Treatments, 2017-2027, $ mn 45
Figure 16. Breakdown of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2020-2027, % of Revenue 46
Figure 17. Contribution to Global 2021-2027 Cumulative Revenue by ALS Type, Value ($ mn) and Share (%) 47
Figure 18. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Sporadic ALS, 2017-2027, $ mn 48
Figure 19. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Familial ALS, 2017-2027, $ mn 49
Figure 20. Breakdown of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2020-2027, % of Revenue 51
Figure 21. Contribution to Global 2021-2027 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 51
Figure 22. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital Pharmacies, 2017-2027, $ mn 52
Figure 23. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Retail Pharmacies, 2017-2027, $ mn 53
Figure 24. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Online Pharmacies, 2017-2027, $ mn 54
Figure 25. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Distribution Channels, 2017-2027, $ mn 55
Figure 26. Global Market Snapshot by Region 56
Figure 27. Geographic Spread of Worldwide Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2020-2027, % of Revenue 57
Figure 28. Contribution to Global 2021-2027 Cumulative Revenue by Region, Value ($ mn) and Share (%) 58
Figure 29. North American Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 61
Figure 30. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 61
Figure 31. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 62
Figure 32. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 64
Figure 33. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 66
Figure 34. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Mexico, 2017-2027, $ mn 68
Figure 35. European Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 71
Figure 36. Breakdown of European Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 71
Figure 37. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 72
Figure 38. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in UK, 2017-2027, $ mn 73
Figure 39. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in France, 2017-2027, $ mn 75
Figure 40. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Germany, 2017-2027, $ mn 77
Figure 41. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Spain, 2017-2027, $ mn 79
Figure 42. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Italy, 2017-2027, $ mn 81
Figure 43. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Russia, 2017-2027, $ mn 83
Figure 44. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of Europe, 2017-2027, $ mn 85
Figure 45. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 88
Figure 46. Breakdown of APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 88
Figure 47. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 89
Figure 48. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in China, 2017-2027, $ mn 90
Figure 49. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Japan, 2017-2027, $ mn 93
Figure 50. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in India, 2017-2027, $ mn 95
Figure 51. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Australia, 2017-2027, $ mn 97
Figure 52. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in South Korea, 2017-2027, $ mn 99
Figure 53. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of APAC, 2017-2027, $ mn 101
Figure 54. South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 104
Figure 55. Breakdown of South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 104
Figure 56. Contribution to South America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 105
Figure 57. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Argentina, 2017-2027, $ mn 106
Figure 58. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Brazil, 2017-2027, $ mn 108
Figure 59. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Chile, 2017-2027, $ mn 110
Figure 60. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of South America, 2017-2027, $ mn 112
Figure 61. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Middle East and Africa (MEA), 2017-2027, $ mn 114
Figure 62. Breakdown of MEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 114
Figure 63. Contribution to MEA 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 115
Figure 64. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in UAE, 2017-2027, $ mn 116
Figure 65. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Saudi Arabia, 2017-2027, $ mn 118
Figure 66. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in South Africa, 2017-2027, $ mn 120
Figure 67. Growth Stage of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Industry over the Forecast Period 123

Table 1. Snapshot of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Balanced Perspective, 2020-2027 19
Table 2. Growth Rate of World GDP, 2020-2022 22
Table 3. Main Product Trends and Market Opportunities in Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 32
Table 4. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 40
Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication by Type, 2017-2027, $ mn 43
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 46
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 50
Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Region, 2017-2027, $ mn 57
Table 9. Leading National Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2020 and 2027, $ mn 59
Table 10. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 62
Table 11. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 65
Table 12. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 65
Table 13. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 65
Table 14. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 67
Table 15. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 67
Table 16. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 67
Table 17. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 69
Table 18. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 69
Table 19. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 69
Table 20. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 72
Table 21. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 74
Table 22. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 74
Table 23. UK Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 74
Table 24. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 76
Table 25. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 76
Table 26. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 76
Table 27. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 78
Table 28. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 78
Table 29. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 78
Table 30. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 80
Table 31. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 80
Table 32. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 80
Table 33. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 82
Table 34. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 82
Table 35. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 82
Table 36. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 84
Table 37. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 84
Table 38. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 84
Table 39. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of Europe by Country, 2017-2027, $ mn 86
Table 40. APAC Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 89
Table 41. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 91
Table 42. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 91
Table 43. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 91
Table 44. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 94
Table 45. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 94
Table 46. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 94
Table 47. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 96
Table 48. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 96
Table 49. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 96
Table 50. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 98
Table 51. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 98
Table 52. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 98
Table 53. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 100
Table 54. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 100
Table 55. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 100
Table 56. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Rest of APAC by Country/Region, 2017-2027, $ mn 102
Table 57. South America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 105
Table 58. Argentina Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 107
Table 59. Argentina Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 107
Table 60. Argentina Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 107
Table 61. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 109
Table 62. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 109
Table 63. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 109
Table 64. Chile Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 111
Table 65. Chile Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 111
Table 66. Chile Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 111
Table 67. MEA Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 115
Table 68. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 117
Table 69. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 117
Table 70. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 117
Table 71. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 119
Table 72. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 119
Table 73. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 119
Table 74. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 121
Table 75. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 121
Table 76. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 121
Table 77. AB Science SA: Company Snapshot 127
Table 78. AB Science SA: Business Segmentation 127
Table 79. AB Science SA: Product Portfolio 128
Table 80. AB Science SA: Revenue, 2017-2019, $ mn 128

Interested in this report?
Get your FREE sample!

Safe and Secure SSl Encryption

Licensing options

3200
USD

Single User License
Site License
Global User License

How client has rates us?

Requirement Gathering & Methodology

Data Collection Techniques

Our Research Team & Data Sourcing

Data Science & Analytical Tools

Data Visualization & Presentation Skills

Project/ Report Delivery & After Sales Services

Testimonial

READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.

PRODUCT DEVELOPMENT MANAGER

CEO

Vivek Arora

BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!

EXECUTIVE DIRECTOR

Rahul Roy

THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.

SALES DIRECTOR

Arjun Prasad

THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH

MARKETING MANAGER

President

Manish Verma

Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

MARKETING DIRECTOR

Gautam Saxena

The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.

PRODUCT MANAGER

Tom Stone

I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.

Associate Director

Mark Wood

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027